Related Experiment Video
Updated: Apr 17, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.6K
Focused information criterion on predictive models in personalized medicine
Hui Yang1, Yutao Liu, Hua Liang
1Medical Science Biostatistics, Amgen Inc, Thousand Oaks, CA, 91320, USA.
Biometrical Journal. Biometrische Zeitschrift
|February 6, 2015
Summary
The focused information criterion (FIC) aids personalized medicine by selecting models that minimize prediction error for individual patient parameters. This approach enhances diagnostic and prognostic accuracy by accounting for individual patient differences.
Area of Science:
- Biostatistics
- Computational Biology
- Personalized Medicine
Background:
- Traditional model selection criteria assess overall model fit, not specific parameter accuracy.
- Personalized medicine requires accurate individual predictions for prognosis and diagnosis.
- Heterogeneity among individuals poses challenges for prediction accuracy.
Purpose of the Study:
- To apply the focused information criterion (FIC) for personalized medicine.
- To develop personalized predictive models using individual-level data.
- To improve prediction accuracy and reduce uncertainty in clinical predictions.
Main Methods:
- Utilizing individual-level data including clinical observations, demographics, and genetics.
- Applying the focused information criterion (FIC) to select the best predictive model for each individual.
- Estimating the mean squared error for the focused parameter of interest.
Main Results:
- Demonstrated the application of FIC in personalized medicine through two real biomedical data examples.
- Showcased how considering individual heterogeneity improves prediction accuracy.
- Successfully developed personalized predictive models for prognosis and diagnosis.
Conclusions:
- The focused information criterion (FIC) is a valuable tool for personalized medicine.
- Individual-level data and FIC application can enhance prognostic and diagnostic capabilities.
- This methodology offers a promising approach to reduce prediction uncertainty in healthcare.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
02:50Combination Therapies and Personalized Medicine
1.9K
1.9K
01:29Pharmacogenomics: Identification of New Drug Targets
98
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
98
01:13Sensitivity, Specificity, and Predicted Value
1.9K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
1.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
580
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
580
01:29Pharmacogenetics and Pharmacogenomics: Overview
202
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
202